Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|NM21-1480||NM21 1480|NM211480|ND 021|ND-021|ND021||NM21-1480 is a recombinant, trispecific monovalent antibody-based molecule that targets PD-L1, 4-1BB and human serum albumin, potentially leading to activation of T cell immune responses and enhanced T cell mediated cytotoxicity and may lead to inhibition of tumor cell proliferation (NCI Drug Dictionary, Cancer Research 80(16), Abstr 2276)|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04442126||Phase Ib/II||NM21-1480||A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors||Recruiting||USA||1|